Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Sanofi pays J&J $175M for late-phase E. coli shot, pushing deeper into vaccines as partner retreats
Fierce Biotech
Tue, 10/3/23 - 10:15 am
Tags:
Sanofi, JNJ, vaccines, E. coli
Johnson & Johnson says it won't enforce secondary patents on tuberculosis med Sirturo
Fierce Pharma
Mon, 10/2/23 - 06:37 pm
Tags:
JNJ, Sirturo, tuberculosis, patents
Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?
Motley Fool
Sun, 10/1/23 - 01:07 pm
Tags:
JNJ, Kenvue, consumer health, spinoffs, dividends
J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug
Reuters
Thu, 09/28/23 - 12:08 pm
Tags:
JNJ, non-small cell lung cancer, AstraZeneca, Rybrevant, lazertinib, Tagrisso
Janssen and Atropos partner to expedite clinical development
Clinical Trials Arena
Thu, 09/28/23 - 10:10 am
Tags:
JNJ, Janssen, Atropos Health, real world data
J&J inks 'first of its kind' pact with Singapore government to boost regional life sciences innovation
Fierce Biotech
Wed, 09/27/23 - 11:47 am
Tags:
JNJ, Singapore, life sciences, JLabs
J&J, IBM face class-action lawsuit over patient data breach
Fierce Pharma
Tue, 09/26/23 - 11:45 am
Tags:
JNJ, IBM, patients, data, cybersecurity
J&J shines light on key role in multiple myeloma care team, vowing to raise awareness and offer support
Fierce Pharma
Tue, 09/26/23 - 10:10 am
Tags:
JNJ, Multiple Myeloma, pharma marketing
After Kenvue spinoff, J&J says it's 'uniting' Janssen and medtech segments under one brand
Fierce Pharma
Thu, 09/14/23 - 11:13 pm
Tags:
JNJ, Janssen, Medtech, rebranding
Johnson & Johnson is getting rid of its script logo after more than 130 years
Stat
Thu, 09/14/23 - 11:09 pm
Tags:
JNJ, logos
Alex Gorsky joins Neurotech’s board as lead director
Ophthalmology Times
Thu, 09/14/23 - 10:10 am
Tags:
Alex Gorsky, neurotech, JNJ
AbbVie’s Skyrizi Outperforms J&J’s Stelara in Late-Stage Crohn’s Disease Trial
BioSpace
Wed, 09/13/23 - 11:36 am
Tags:
AbbVie, Skyrizi, JNJ, Stelara, Crohn's Disease, clinical trials
Doctor asks court to toss J&J lawsuit against her over cancer research
Reuters
Wed, 09/13/23 - 11:26 am
Tags:
JNJ, legal, free speech
Sandoz to Commercialize Samsung Bioepis’ Biosimilar to J&J’s Stelara
BioSpace
Tue, 09/12/23 - 10:40 am
Tags:
Sandoz, Samsung Bioepis, biosimilars, JNJ, Stelara
Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Fierce Pharma
Fri, 09/8/23 - 10:29 am
Tags:
M&A, patent cliffs, Merck, JNJ, Pfizer, GSK, Novartis, Eli Lilly, Novo Nordisk
J&J's patient assistance program suffers data breach, IBM says
Fierce Pharma
Thu, 09/7/23 - 09:43 am
Tags:
JNJ, Janssen, IBM, patient assistance programs, cybersecurity
J&J sends blood pressure drug back to Idorsia
BioPharma Dive
Wed, 09/6/23 - 11:54 am
Tags:
Idorsia, JNJ, aprocitentan, hypertension
Despite price drops, J&J gets little reprieve from TB drug saga
Medical Marketing and Media
Wed, 09/6/23 - 10:12 am
Tags:
JNJ, tuberculosis, generics, bedaquiline
Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?
Motley Fool
Thu, 08/31/23 - 11:01 am
Tags:
Medicare, JNJ, drug pricing
Johnson & Johnson's spinoff of Kenvue provides $13.2B in potential M&A firepower
Fierce Pharma
Wed, 08/30/23 - 11:29 pm
Tags:
JNJ, M&A, consumer health, Kenvue

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.